{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:10:13Z","timestamp":1764601813845},"reference-count":58,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,4]]},"DOI":"10.7759\/cureus.61674","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T18:45:13Z","timestamp":1717526713000},"source":"Crossref","is-referenced-by-count":1,"title":["Hypereosinophilia and Left Ventricular Thrombus: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Aleksan","family":"Khachatryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakob","family":"Harutyunyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Psotka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashot","family":"Batikyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tufan","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Khorsandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Alejandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahagn","family":"Tamazyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Sargsyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26352","article-title":"World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Shomali W","year":"2022","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:129-48. 10.1002\/ajh.26352","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19812","article-title":"Association of thrombosis with hypereosinophilic syndrome in patients with genetic alterations","volume":"4","author":"Leiva O","year":"2021","unstructured":"Leiva O, Baker O, Jenkins A, et al.. Association of thrombosis with hypereosinophilic syndrome in patients with genetic alterations. JAMA Netw Open. 2021, 4:e2119812. 10.1001\/jamanetworkopen.2021.19812","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.12.1105","article-title":"Hypereosinophilic syndrome and thrombosis: a retrospective review","volume":"131","author":"Wallace KL","year":"2013","unstructured":"Wallace KL, Elias MK, Butterfield JH, Weiler CR. Hypereosinophilic syndrome and thrombosis: a retrospective review. J Allergy Clin Immunol. 2013, 131:AB122.","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-551614","article-title":"How I treat hypereosinophilic syndromes","volume":"126","author":"Klion AD","year":"2015","unstructured":"Klion AD. How I treat hypereosinophilic syndromes. Blood. 2015, 126:1069-77. 10.1182\/blood-2014-11-551614","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1018394","article-title":"Case report: application of non-VKA oral anticoagulants in patient of idiopathic hypereosinophilic syndrome with intracardiac thrombus","volume":"13","author":"Zou M","year":"2022","unstructured":"Zou M, Liu G, Li Y. Case report: application of non-VKA oral anticoagulants in patient of idiopathic hypereosinophilic syndrome with intracardiac thrombus. Front Pharmacol. 2022, 13:1018394. 10.3389\/fphar.2022.1018394","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-68-6-1220","article-title":"The hypereosinophilic syndromes","volume":"68","author":"Hardy WR","year":"1968","unstructured":"Hardy WR, Anderson RE. The hypereosinophilic syndromes. Ann Intern Med. 1968, 68:1220-9. 10.7326\/0003-4819-68-6-1220","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid MJ","year":"1975","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975, 54:1-27.","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.03.035","article-title":"Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence","volume":"126","author":"Crane MM","year":"2010","unstructured":"Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence. J Allergy Clin Immunol. 2010, 126:179-81. 10.1016\/j.jaci.2010.03.035","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu PU","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, et al.. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009, 124:1319-25.e3. 10.1016\/j.jaci.2009.09.022","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller PF","year":"1994","unstructured":"Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994, 83:2759-79.","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.114.001130","article-title":"Management of a patient with eosinophilic myocarditis and normal peripheral eosinophil count: case report and literature review","volume":"7","author":"Fozing T","year":"2014","unstructured":"Fozing T, Zouri N, Tost A, Breit R, Seeck G, Koch C, Oezbek C. Management of a patient with eosinophilic myocarditis and normal peripheral eosinophil count: case report and literature review. Circ Heart Fail. 2014, 7:692-4. 10.1161\/CIRCHEARTFAILURE.114.001130","journal-title":"Circ Heart Fail"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.023","article-title":"Eosinophilic myocarditis: characteristics, treatment, and outcomes","volume":"70","author":"Brambatti M","year":"2017","unstructured":"Brambatti M, Matassini MV, Adler ED, Klingel K, Camici PG, Ammirati E. Eosinophilic myocarditis: characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017, 70:2363-75. 10.1016\/j.jacc.2017.09.023","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s003920050183","article-title":"[L\u00f6ffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia] (Article in German)","volume":"87","author":"Hagendorff A","year":"1998","unstructured":"Hagendorff A, H\u00fcmmelgen M, Omran H, et al.. [L\u00f6ffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia] (Article in German). Z Kardiol. 1998, 87:293-9. 10.1007\/s003920050183","journal-title":"Z Kardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90605-7","article-title":"Dilated cardiomyopathy in the idiopathic hypereosinophilic syndrome","volume":"52","author":"DePace NL","year":"1983","unstructured":"DePace NL, Nestico PF, Morganroth J, et al.. Dilated cardiomyopathy in the idiopathic hypereosinophilic syndrome. Am J Cardiol. 1983, 52:1359-60. 10.1016\/0002-9149(83)90605-7","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01741392","article-title":"Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome","volume":"67","author":"Christen R","year":"1989","unstructured":"Christen R, Morant R, Schneider J, Jenni R, Fehr J. Progressive dilated cardiomyopathy in a patient with longstanding and complete prednisone-induced hematological remission of idiopathic hypereosinophilic syndrome. Klin Wochenschr. 1989, 67:358-65. 10.1007\/BF01741392","journal-title":"Klin Wochenschr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960110713","article-title":"Severe constrictive pericarditis as an unsuspected cause of death in a patient with idiopathic hypereosinophilic syndrome and restrictive cardiomyopathy","volume":"11","author":"Lui CY","year":"1988","unstructured":"Lui CY, Makoui C. Severe constrictive pericarditis as an unsuspected cause of death in a patient with idiopathic hypereosinophilic syndrome and restrictive cardiomyopathy. Clin Cardiol. 1988, 11:502-4. 10.1002\/clc.4960110713","journal-title":"Clin Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111862","article-title":"Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis","volume":"9","author":"Cugno M","year":"2014","unstructured":"Cugno M, Marzano AV, Lorini M, Carbonelli V, Tedeschi A. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS One. 2014, 9:e111862. 10.1371\/journal.pone.0111862","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004945","article-title":"Eosinophils are a major intravascular location for tissue factor storage and exposure","volume":"109","author":"Moosbauer C","year":"2007","unstructured":"Moosbauer C, Morgenstern E, Cuvelier SL, et al.. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007, 109:995-1002. 10.1182\/blood-2006-02-004945","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116382","article-title":"Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease","volume":"91","author":"Slungaard A","year":"1993","unstructured":"Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest. 1993, 91:1721-30. 10.1172\/JCI116382","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.4.1271","article-title":"Activation of platelets by eosinophil granule proteins","volume":"172","author":"Rohrbach MS","year":"1990","unstructured":"Rohrbach MS, Wheatley CL, Slifman NR, Gleich GJ. Activation of platelets by eosinophil granule proteins. J Exp Med. 1990, 172:1271-4. 10.1084\/jem.172.4.1271","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-2152","article-title":"The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states","volume":"107","author":"Wang JG","year":"2006","unstructured":"Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood. 2006, 107:558-65. 10.1182\/blood-2005-05-2152","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.67.3.572","article-title":"Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization","volume":"67","author":"Gottdiener JS","year":"1983","unstructured":"Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC, Fauci AS. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization. Circulation. 1983, 67:572-8. 10.1161\/01.cir.67.3.572","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12691\/ajmcr-9-4-10","article-title":"Hypereosinophilia and L\u00f6ffler\u2019s endocarditis: a systematic review","volume":"9","author":"Kariyanna PT","year":"2021","unstructured":"Kariyanna PT, Hossain NA, Onkaramurthy NJ, Jayarangaiah A, Hossain NA, Jayarangaiah A, McFarlane IM. Hypereosinophilia and L\u00f6ffler\u2019s endocarditis: a systematic review. Am J Med Case Rep. 2021, 9:241-8. 10.12691\/ajmcr-9-4-10","journal-title":"Am J Med Case Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1179547617723643","article-title":"Loeffler endocarditis: a unique presentation of right-sided heart failure due to eosinophil-induced endomyocardial fibrosis","volume":"10","author":"Alam A","year":"2017","unstructured":"Alam A, Thampi S, Saba SG, Jermyn R. Loeffler endocarditis: a unique presentation of right-sided heart failure due to eosinophil-induced endomyocardial fibrosis. Clin Med Insights Case Rep. 2017, 10:1179547617723643. 10.1177\/1179547617723643","journal-title":"Clin Med Insights Case Rep"},{"key":"ref25","article-title":"Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis","volume":"140","author":"Noguchi H","year":"1992","unstructured":"Noguchi H, Kephart GM, Colby TV, Gleich GJ. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol. 1992, 140:521-8.","journal-title":"Am J Pathol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15327.x","article-title":"Transforming growth factors and the regulation of cell proliferation","volume":"187","author":"Lyons RM","year":"1990","unstructured":"Lyons RM, Moses HL. Transforming growth factors and the regulation of cell proliferation. Eur J Biochem. 1990, 187:467-73. 10.1111\/j.1432-1033.1990.tb15327.x","journal-title":"Eur J Biochem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/0304-419x(90)90013-q","article-title":"The cell biology of transforming growth factor beta","volume":"1032","author":"Barnard JA","year":"1990","unstructured":"Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor beta. Biochim Biophys Acta. 1990, 1032:79-87. 10.1016\/0304-419x(90)90013-q","journal-title":"Biochim Biophys Acta"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02443-2","article-title":"Loeffler endocarditis with intracardiac thrombus: case report and literature review","volume":"21","author":"Zhang Q","year":"2021","unstructured":"Zhang Q, Si D, Zhang Z, Zhang W. Loeffler endocarditis with intracardiac thrombus: case report and literature review. BMC Cardiovasc Disord. 2021, 21:615. 10.1186\/s12872-021-02443-2","journal-title":"BMC Cardiovasc Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90227-4","article-title":"The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature","volume":"67","author":"Parrillo JE","year":"1997","unstructured":"Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci\u00a0AS. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med. 1997, 67:572-82. 10.1016\/0002-9343(79)90227-4","journal-title":"Am J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-97-1-78","article-title":"NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations","volume":"97","author":"Fauci AS","year":"1982","unstructured":"Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982, 97:78-92. 10.7326\/0003-4819-97-1-78","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1982.tb02339.x","article-title":"The hypereosinophilic syndrome: clinical features, laboratory findings and treatment","volume":"37","author":"Spry CJ","year":"1982","unstructured":"Spry CJ. The hypereosinophilic syndrome: clinical features, laboratory findings and treatment. Allergy. 1982, 37:539-51. 10.1111\/j.1398-9995.1982.tb02339.x","journal-title":"Allergy"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307959","article-title":"Hypereosinophilic syndrome: cardiac diagnosis and management","volume":"102","author":"Mankad R","year":"2016","unstructured":"Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic syndrome: cardiac diagnosis and management. Heart. 2016, 102:100-6. 10.1136\/heartjnl-2015-307959","journal-title":"Heart"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2020.09.002","article-title":"Loeffler\u2019s endocarditis: an integrated multimodality approach","volume":"33","author":"Polito MV","year":"2020","unstructured":"Polito MV, Hagendorff A, Citro R, et al.. Loeffler\u2019s endocarditis: an integrated multimodality approach. J Am Soc Echocardiogr. 2020, 33:1427-41. 10.1016\/j.echo.2020.09.002","journal-title":"J Am Soc Echocardiogr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-007-0029-5","article-title":"Unusual case of aortic valve involvement in patient with L\u00f6ffler's endomyocarditis: management, follow-up and short review of the literature","volume":"24","author":"Bozcali E","year":"2007","unstructured":"Bozcali E, Aliyev F, Agac MT, Erkan H, Okcun B, Babalik E, Karpuz H. Unusual case of aortic valve involvement in patient with L\u00f6ffler's endomyocarditis: management, follow-up and short review of the literature. J Thromb Thrombolysis. 2007, 24:309-13. 10.1007\/s11239-007-0029-5","journal-title":"J Thromb Thrombolysis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12368","article-title":"Transthoracic echocardiographic detection of pulmonary valve involvement in L\u00f6effler's endocarditis","volume":"31","author":"Garg A","year":"2014","unstructured":"Garg A, Nanda NC, Sungur A, Sharma GL, Mehta KJ, \u00d6z TK. Transthoracic echocardiographic detection of pulmonary valve involvement in L\u00f6effler's endocarditis. Echocardiography. 2014, 31:83-6. 10.1111\/echo.12368","journal-title":"Echocardiography"},{"key":"ref36","article-title":"Recurrent native and prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome","volume":"23","author":"Zakhama L","year":"2014","unstructured":"Zakhama L, Slama I, Boussabah E, et al.. Recurrent native and prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome. J Heart Valve Dis. 2014, 23:168-70.","journal-title":"J Heart Valve Dis"},{"key":"ref37","article-title":"Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome","volume":"11","author":"Watanabe K","year":"2002","unstructured":"Watanabe K, Tournilhac O, Camilleri LF. Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome. J Heart Valve Dis. 2002, 11:447-9.","journal-title":"J Heart Valve Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.03.059","article-title":"Hypereosinophilic syndrome: a rare case of Loeffler's endocarditis documented in cardiac MRI","volume":"149","author":"Kleinfeldt T","year":"2011","unstructured":"Kleinfeldt T, Ince H, Nienaber CA. Hypereosinophilic syndrome: a rare case of Loeffler's endocarditis documented in cardiac MRI. Int J Cardiol. 2011, 149:e30-2. 10.1016\/j.ijcard.2009.03.059","journal-title":"Int J Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcu211","article-title":"The 'V' sign of endomyocardial fibrosis","volume":"108","author":"Jariwala N","year":"2015","unstructured":"Jariwala N, McGraw S, Rangarajan VS, Mirza O, Wong J, Farzaneh-Far A. The 'V' sign of endomyocardial fibrosis. QJM. 2015, 108:423-4. 10.1093\/qjmed\/hcu211","journal-title":"QJM"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.110.950675","article-title":"Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients","volume":"4","author":"Salemi VM","year":"2011","unstructured":"Salemi VM, Rochitte CE, Shiozaki AA, et al.. Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging. 2011, 4:304-11. 10.1161\/CIRCIMAGING.110.950675","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-10-21","article-title":"Time course of eosinophilic myocarditis visualized by CMR","volume":"10","author":"Debl K","year":"2008","unstructured":"Debl K, Djavidani B, Buchner S, et al.. Time course of eosinophilic myocarditis visualized by CMR. J Cardiovasc Magn Reson. 2008, 10:21. 10.1186\/1532-429X-10-21","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.01.019","article-title":"Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease","volume":"126","author":"Syed IS","year":"2008","unstructured":"Syed IS, Martinez MW, Feng DL, Glockner JF. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol. 2008, 126:e50-2. 10.1016\/j.ijcard.2007.01.019","journal-title":"Int J Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2015.10.015","article-title":"Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy","volume":"69","author":"Dominguez F","year":"2016","unstructured":"Dominguez F, K\u00fchl U, Pieske B, Garcia-Pavia P, Tsch\u00f6pe C. Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy. Rev Esp Cardiol (Engl Ed). 2016, 69:178-87. 10.1016\/j.rec.2015.10.015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-3-201","article-title":"Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment","volume":"115","author":"Getz MA","year":"1991","unstructured":"Getz MA, Subramanian R, Logemann T, Ballantyne F. Acute necrotizing eosinophilic myocarditis as a manifestation of severe hypersensitivity myocarditis. Antemortem diagnosis and successful treatment. Ann Intern Med. 1991, 115:201-2. 10.7326\/0003-4819-115-3-201","journal-title":"Ann Intern Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.case.2017.12.003","article-title":"Intracardiac thrombus in leukemia: role of cardiac magnetic resonance imaging in eosinophilic myocarditis","volume":"2","author":"Allderdice C","year":"2018","unstructured":"Allderdice C, Marcu C, Kabirdas D. Intracardiac thrombus in leukemia: role of cardiac magnetic resonance imaging in eosinophilic myocarditis. CASE (Phila). 2018, 2:114-7. 10.1016\/j.case.2017.12.003","journal-title":"CASE (Phila)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1103005","article-title":"Eosinophil granule protein localization in eosinophilic endomyocardial disease","volume":"365","author":"Wright BL","year":"2011","unstructured":"Wright BL, Leiferman KM, Gleich GJ. Eosinophil granule protein localization in eosinophilic endomyocardial disease. N Engl J Med. 2011, 365:187-8. 10.1056\/NEJMc1103005","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90348-4","article-title":"Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa","volume":"94","author":"Butterfield JH","year":"1994","unstructured":"Butterfield JH, Gleich GJ. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol. 1994, 94:1318-26. 10.1016\/0091-6749(94)90348-4","journal-title":"J Allergy Clin Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-08-2798","article-title":"Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome","volume":"103","author":"Klion AD","year":"2004","unstructured":"Klion AD, Robyn J, Akin C, et al.. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 2004, 103:473-8. 10.1182\/blood-2003-08-2798","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07033.x","article-title":"A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients","volume":"141","author":"Helbig G","year":"2008","unstructured":"Helbig G, Stella-Ho\u0142owiecka B, Majewski M, et al.. A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. Br J Haematol. 2008, 141:200-4. 10.1111\/j.1365-2141.2008.07033.x","journal-title":"Br J Haematol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100164","article-title":"Relapse following discontinuation of imatinib mesylate therapy for FIP1L1\/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing","volume":"110","author":"Klion AD","year":"2007","unstructured":"Klion AD, Robyn J, Maric I, et al.. Relapse following discontinuation of imatinib mesylate therapy for FIP1L1\/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing. Blood. 2007, 110:3552-6. 10.1182\/blood-2007-07-100164","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.027","article-title":"Novel targeted therapies for eosinophilic disorders","volume":"130","author":"Wechsler ME","year":"2012","unstructured":"Wechsler ME, Fulkerson PC, Bochner BS, et al.. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol. 2012, 130:563-71. 10.1016\/j.jaci.2012.07.027","journal-title":"J Allergy Clin Immunol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.055","article-title":"Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes","volume":"131","author":"Roufosse FE","year":"2013","unstructured":"Roufosse FE, Kahn JE, Gleich GJ, et al.. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol. 2013, 131:461-7.e1-5. 10.1016\/j.jaci.2012.07.055","journal-title":"J Allergy Clin Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of patients with the hypereosinophilic syndrome with mepolizumab","volume":"358","author":"Rothenberg ME","year":"2008","unstructured":"Rothenberg ME, Klion AD, Roufosse FE, et al.. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med. 2008, 358:1215-28. 10.1056\/NEJMoa070812","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05211.x","article-title":"Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia","volume":"90","author":"Mukai HY","year":"1995","unstructured":"Mukai HY, Ninomiya H, Ohtani K, Nagasawa T, Abe T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol. 1995, 90:892-9. 10.1111\/j.1365-2141.1995.tb05211.x","journal-title":"Br J Haematol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100915","article-title":"Literature reviews of stroke with hypereosinophilic syndrome","volume":"37","author":"Ono R","year":"2021","unstructured":"Ono R, Iwahana T, Kato H, Okada S, Kobayashi Y. Literature reviews of stroke with hypereosinophilic syndrome. Int J Cardiol Heart Vasc. 2021, 37:100915. 10.1016\/j.ijcha.2021.100915","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine GN","year":"2022","unstructured":"Levine GN, McEvoy JW, Fang JC, et al.. Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association. Circulation. 2022, 146:e205-23. 10.1161\/CIR.0000000000001092","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/s1010-7940(99)00027-5","article-title":"Surgery for endomyocardial fibrosis revisited","volume":"15","author":"Moraes F","year":"1999","unstructured":"Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, Moraes CR. Surgery for endomyocardial fibrosis revisited. Eur J Cardiothorac Surg. 1999, 15:309-12. 10.1016\/s1010-7940(99)00027-5","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90929-9","article-title":"Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome","volume":"73","author":"Harley JB","year":"1982","unstructured":"Harley JB, McIntosh CL, Kirklin JJ, Maron BJ, Gottdiener J, Roberts WC, Fauci AS. Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome. Am J Med. 1982, 73:77-81. 10.1016\/0002-9343(82)90929-9","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259759-hypereosinophilia-and-left-ventricular-thrombus-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T18:45:48Z","timestamp":1717526748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259759-hypereosinophilia-and-left-ventricular-thrombus-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":58,"URL":"https:\/\/doi.org\/10.7759\/cureus.61674","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}